Article: SelectScience – Accessible, rapid testing transforms prostate cancer detection

With prostate cancer now the most common cancer in the UK, Valley Diagnostics is developing rapid, accurate, and cost-effective lateral flow tests for prostate cancer and aims to make early diagnosis more accessible and reliable. In this interview, Dave Taylor, CEO of Valley Diagnostics, shares insights into the challenges of prostate cancer testing today, the potential of novel biomarker-based LFTs, and how the company’s innovations could reshape the future of cancer diagnostics. Read the article in full on SelectScience here.